Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1Hypertension 1

Interventions

relacorilant 5Nutrition Assessment 4Hydrochlorothiazide 4Bevacizumab 3Amlodipine 3aliskiren 2Osilodrostat 2Lisinopril 2Labetalol 2Angiotensin-Converting Enzyme Inhibitors 2Adrenalectomy 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1pazopanib 1lutetium Lu 177 dotatate 1ganirelix 1gallium Ga 68 dotatate 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1benazepril 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypertension × fimasartan × Clear all
NCT02222480 2016-07-01

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Boryung Pharmaceutical Co., Ltd

Phase 2 Completed
103 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡